Mitsubishi UFJ Trust & Banking
REGN icon

Mitsubishi UFJ Trust & Banking’s Regeneron Pharmaceuticals REGN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$36.1M Buy
68,744
+204
+0.3% +$107K 0.08% 258
2025
Q1
$43.5M Sell
68,540
-2,108
-3% -$1.34M 0.11% 199
2024
Q4
$50.3M Sell
70,648
-5,676
-7% -$4.04M 0.12% 188
2024
Q3
$80.2M Sell
76,324
-1,604
-2% -$1.69M 0.18% 118
2024
Q2
$81.9M Sell
77,928
-7,865
-9% -$8.27M 0.2% 109
2024
Q1
$82.6M Sell
85,793
-3,678
-4% -$3.54M 0.19% 121
2023
Q4
$78.6M Sell
89,471
-973
-1% -$855K 0.19% 130
2023
Q3
$74.4M Sell
90,444
-46,138
-34% -$38M 0.19% 122
2023
Q2
$98.1M Sell
136,582
-241
-0.2% -$173K 0.23% 102
2023
Q1
$112M Sell
136,823
-16,209
-11% -$13.3M 0.27% 89
2022
Q4
$110M Sell
153,032
-25,220
-14% -$18.2M 0.29% 89
2022
Q3
$123M Sell
178,252
-16,072
-8% -$11.1M 0.34% 68
2022
Q2
$115M Buy
194,324
+8,699
+5% +$5.14M 0.29% 83
2022
Q1
$130M Sell
185,625
-2,009
-1% -$1.4M 0.3% 82
2021
Q4
$118M Buy
187,634
+16,040
+9% +$10.1M 0.24% 107
2021
Q3
$104M Buy
171,594
+2,860
+2% +$1.73M 0.22% 112
2021
Q2
$93.3M Sell
168,734
-5,207
-3% -$2.88M 0.2% 131
2021
Q1
$82.9M Buy
173,941
+34,568
+25% +$16.5M 0.18% 134
2020
Q4
$67.3M Buy
139,373
+12,959
+10% +$6.26M 0.14% 183
2020
Q3
$70.8M Buy
126,414
+147
+0.1% +$82.3K 0.16% 152
2020
Q2
$78.7M Buy
126,267
+47,492
+60% +$29.6M 0.19% 131
2020
Q1
$38.5M Buy
78,775
+4,303
+6% +$2.1M 0.11% 210
2019
Q4
$28M Buy
74,472
+170
+0.2% +$63.8K 0.07% 328
2019
Q3
$20.3M Buy
74,302
+1,518
+2% +$415K 0.05% 373
2019
Q2
$22.6M Buy
72,784
+4,468
+7% +$1.39M 0.08% 307
2019
Q1
$27.7M Buy
68,316
+2,153
+3% +$872K 0.1% 239
2018
Q4
$24.7M Buy
66,163
+2,807
+4% +$1.05M 0.1% 235
2018
Q3
$25.6M Sell
63,356
-102,123
-62% -$41.3M 0.09% 262
2018
Q2
$57.1M Buy
165,479
+2,503
+2% +$864K 0.1% 235
2018
Q1
$56.1M Buy
162,976
+4,636
+3% +$1.6M 0.1% 231
2017
Q4
$59.5M Buy
158,340
+136
+0.1% +$51.1K 0.1% 220
2017
Q3
$70.7M Sell
158,204
-203
-0.1% -$90.8K 0.13% 184
2017
Q2
$77.8M Buy
158,407
+1,730
+1% +$850K 0.15% 156
2017
Q1
$60.7M Buy
156,677
+191
+0.1% +$74K 0.12% 200
2016
Q4
$57.4M Sell
156,486
-2,082
-1% -$764K 0.12% 199
2016
Q3
$63.7M Buy
158,568
+2,263
+1% +$910K 0.13% 187
2016
Q2
$54.6M Buy
156,305
+2,691
+2% +$940K 0.12% 204
2016
Q1
$55.4M Buy
153,614
+4,610
+3% +$1.66M 0.12% 193
2015
Q4
$80.9M Buy
149,004
+801
+0.5% +$435K 0.18% 133
2015
Q3
$68.9M Buy
148,203
+3,975
+3% +$1.85M 0.17% 141
2015
Q2
$73.6M Sell
144,228
-6,618
-4% -$3.38M 0.17% 145
2015
Q1
$68.1M Buy
150,846
+5,790
+4% +$2.61M 0.16% 159
2014
Q4
$59.5M Buy
145,056
+2,524
+2% +$1.04M 0.14% 175
2014
Q3
$51.4M Sell
142,532
-5,206
-4% -$1.88M 0.13% 191
2014
Q2
$41.7M Buy
147,738
+1,181
+0.8% +$334K 0.1% 256
2014
Q1
$44M Buy
146,557
+2,931
+2% +$880K 0.11% 234
2013
Q4
$39.5M Sell
143,626
-1,652
-1% -$455K 0.1% 246
2013
Q3
$45.5M Buy
145,278
+2,731
+2% +$854K 0.12% 199
2013
Q2
$32.1M Buy
+142,547
New +$32.1M 0.09% 265